General information about company

Scrip code539378
NSE Symbol
MSEI Symbol
ISININE848R01018
Name of the entitySONI MEDICARE LIMITED
Date of start of financial year01-04-2019
Date of end of financial year31-03-2020
Reporting QuarterYearly
Date of Report31-03-2020
Risk management committeeNot Applicable
Market Capitalisation as per immediate previous Financial YearAny other



Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory
Wether the listed entity has a Regular ChairpersonYes
Whether Chairperson is related to MD or CEOYes
SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of BirthWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity (Refer Regulation 17A(1) of Listing RegulationsNumber of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
1MrBIMAL ROY SONI AFPPS1588H00716246Executive DirectorChairpersonMD10-12-1955NA02-08-198826-09-20171000
2MrMAHAVIR PRASAD YADAV AARPY8838K05249381Non-Executive - Independent DirectorNot Applicable10-08-1950NA06-01-2015601121
3MrSUMER CHAND JAIN ACUPJ8426H00254274Non-Executive - Independent DirectorNot Applicable24-04-1955NA20-02-200306-02-2020601110
4MrsANJU SONI AFPPS1706M00716193Non-Executive - Non Independent DirectorNot Applicable09-08-1956NA02-08-19881021



I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory

Wether the listed entity has a Regular Chairperson

SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of BirthWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity (Refer Regulation 17A(1) of Listing RegulationsNumber of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Notes for not providing PANNotes for not providing DIN
5MrsMAMTA SHARMA AHXPS6519E07060149Non-Executive - Independent DirectorNot Applicable21-12-1955NA06-01-2015601120
6MrNAVEEN SANGHI AGBPS0499Q00270432Non-Executive - Independent DirectorNot Applicable04-07-1970NA30-09-2019601100




Audit Committee Details

Whether the Audit Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
105249381MAHAVIR PRASAD YADAV Non-Executive - Independent DirectorChairperson06-01-2015
200716193ANJU SONI Non-Executive - Non Independent DirectorMember30-09-2015
307060149MAMTA SHARMA Non-Executive - Independent DirectorMember06-01-2015


Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
105249381MAHAVIR PRASAD YADAV Non-Executive - Independent DirectorMember06-01-2015
200716193ANJU SONI Non-Executive - Non Independent DirectorMember30-09-2015
307060149MAMTA SHARMA Non-Executive - Independent DirectorMember06-01-2015
400254274SUMER CHAND JAIN Non-Executive - Independent DirectorChairperson06-01-201506-02-2020


Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100716193ANJU SONI Non-Executive - Non Independent DirectorChairperson30-09-2015
200254274SUMER CHAND JAIN Non-Executive - Independent DirectorMember06-01-201506-02-2020
305249381MAHAVIR PRASAD YADAV Non-Executive - Independent DirectorMember06-01-2015
407060149MAMTA SHARMA Non-Executive - Independent DirectorMember30-09-2015


Risk Management Committee

Whether the Risk Management Committee has a Regular ChairpersonNo
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a Regular ChairpersonNo
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Other Committee

SrDIN NumberName of Committee membersName of other committeeCategory 1 of directorsCategory 2 of directorsRemarks

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Disclosure of notes on meeting of board of directors explanatory
SrDate(s) of meeting (if any) in the previous quarterDate(s) of meeting (if any) in the current quarterMaximum gap between any two consecutive (in number of days)Notes for not providing DateWhether requirement of Quorum met (Yes/No)Number of Directors present*No. of Independent Directors attending the meeting*
114-11-2019Yes64
220-01-202066Yes64
306-02-202016Yes53
413-02-20206Yes53



Annexure 1

IV. Meeting of Committees

Disclosure of notes on meeting of committees explanatory
SrName of CommitteeDate(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)Maximum gap between any two consecutive (in number of days)Name of other committeeReson for not providing dateWhether requirement of Quorum met (Yes/No)Number of Directors present*No. of Independent Directors attending the meeting*
1Audit Committee14-11-2019Yes33
2Nomination and remuneration committee01-01-202047Yes44
3Nomination and remuneration committee06-02-202035Yes33
4Audit Committee13-02-20206Yes33



Annexure 1

V. Related Party Transactions

SrSubjectCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
1Whether prior approval of audit committee obtainedYes
2Whether shareholder approval obtained for material RPTNA
3Whether details of RPT entered into pursuant to omnibus approval have been reviewed by Audit CommitteeYes
Disclosure of notes on related party transactions Textual Information(1)
Disclosure of notes of material transaction with related partyTextual Information(2)


Text Block

Textual Information(1)

SONI MEDICARE LIMITED                                                             

                                                               

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JANUARY 20 TO MARCH 20                                                    

                                                               

S.NO.    NAME OF PERSON / PARTY          RELATION            TRASACTION      AMOUNT

1              DR. BIMAL ROY SONI      MANAGING DIRECTOR   CONSULTANCY  2,40,000.00

                                                                                                      LEASE RENT - BUILDING           1,20,000.00

                                                               

2              DR. ANJU SONI  DIRECTOR            CONSULTANCY  5,25,000.00

                                                               

3              MR. NAMIT SONI              SON OF DIRECTOR           SALARY 3,00,000.00

                                                               

4              MRS. NEHA SONI              DAUGHTER IN LAW OF DIRECTOR              SALARY 1,80,000.00

                                                               

5              M/S S S PHARMACY         PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER               MEDICINE AND MEDICAL CONSUMABLES PURCHASED       37,34,162.00

Textual Information(2)

SONI MEDICARE LIMITED                                                             

                                                               

DETAILS OF RELATED PARTY TRANSACTION DURING THE QUARTER JANUARY 20 TO MARCH 20                                                    

                                                               

S.NO.    NAME OF PERSON / PARTY          RELATION            TRASACTION      AMOUNT

1              DR. BIMAL ROY SONI      MANAGING DIRECTOR   CONSULTANCY  2,40,000.00

                                                                                                      LEASE RENT - BUILDING           1,20,000.00

                                                               

2              DR. ANJU SONI  DIRECTOR            CONSULTANCY  5,25,000.00

                                                               

3              MR. NAMIT SONI              SON OF DIRECTOR           SALARY 3,00,000.00

                                                               

4              MRS. NEHA SONI              DAUGHTER IN LAW OF DIRECTOR              SALARY 1,80,000.00

                                                               

5              M/S S S PHARMACY         PARTNERSHIP FIRM IN WHICH DIRECTORS ARE PARTNER               MEDICINE AND MEDICAL CONSUMABLES PURCHASED       37,34,162.00






Annexure 1

VI. Affirmations

SrSubjectCompliance status (Yes/No)
1The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015Yes
2The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit CommitteeYes
3The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committeeYes
4The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committeeYes
5The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 500 listed entities)NA
6The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
7The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
8This report and/or the report submitted in the previous quarter has been placed before Board of Directors.Yes

Annexure 1

SrSubjectCompliance status
1Name of signatorySWEETY MAMODIA
2DesignationCompany Secretary and Compliance Officer



Text Block




Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.Web address
1Details of businessYeshttps://www.sonihospitals.com/
2Terms and conditions of appointment of independent directorsYeshttps://www.sonihospitals.com/
3Composition of various committees of board of directorsYeshttps://www.sonihospitals.com/
4Code of conduct of board of directors and senior management personnelYeshttps://www.sonihospitals.com/
5Details of establishment of vigil mechanism/ Whistle Blower policyYeshttps://www.sonihospitals.com/
6Criteria of making payments to non-executive directorsYeshttps://www.sonihospitals.com/
7Policy on dealing with related party transactionsYeshttps://www.sonihospitals.com/
8Policy for determining ‘material’ subsidiariesNA
9Details of familiarization programmes imparted to independent directorsNA

Annexure II

Annexure II to be submitted by listed entity at the end of the financial year (for the whole of financial year)

I. Disclosure on website in terms of Listing Regulations

SrItemCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.Web address
10Contact information of the designated officials of the listed entity who are responsible for assisting and handling investor grievancesYeshttps://www.sonihospitals.com/
11email address for grievance redressal and other relevant detailsYeshttps://www.sonihospitals.com/
12Financial resultsYeshttps://www.sonihospitals.com/
13Shareholding patternYeshttps://www.sonihospitals.com/
14Details of agreements entered into with the media companies and/or their associatesNA
15Schedule of analyst or institutional investor meet and presentations made by the listed entity to analysts or institutional investors simultaneously with submission to stock exchangeNA
16New name and the old name of the listed entityNA
17Advertisements as per regulation 47 (1)Yeshttps://www.sonihospitals.com/
18Credit rating or revision in credit rating obtainedNA
19Separate audited financial statements of each subsidiary of the listed entity in respect of a relevant financial yearNA
20Whether company has provided information under separate section on its website as per Regulation 46(2)Yeshttps://www.sonihospitals.com/
21Materiality Policy as per Regulation 30NA
22Dividend Distribution policy as per Regulation 43A (as applicable)NA
23It is certified that these contents on the website of the listed entity are correctYeshttps://www.sonihospitals.com/


Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
1Independent director(s) have been appointed in terms of specified criteria of ‘independence’ and/or ‘eligibility’16(1)(b) & 25(6)Yes
2Board composition17(1), 17(1A) & 17(1B)Yes
3Meeting of Board of directors17(2)Yes
4Quorum of Board meeting17(2A)Yes
5Review of Compliance Reports17(3)Yes
6Plans for orderly succession for appointments17(4)Yes
7Code of Conduct17(5)Yes
8Fees/compensation17(6)Yes
9Minimum Information17(7)Yes
10Compliance Certificate17(8)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
11Risk Assessment & Management17(9)Yes
12Performance Evaluation of Independent Directors17(10)Yes
13Recommendation of Board17(11)Yes
14Maximum number of Directorships17ANA
15Composition of Audit Committee18(1)Yes
16Meeting of Audit Committee18(2)Yes
17Composition of nomination & remuneration committee19(1) & (2)Yes
18Quorum of Nomination and Remuneration Committee meeting19(2A)Yes
19Meeting of Nomination and Remuneration Committee19(3A)Yes
20Composition of Stakeholder Relationship Committee20(1), 20(2) & 20(2A)Yes

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
21Meeting of Stakeholders Relationship Committee20(3A)Yes
22Composition and role of risk management committee21(1),(2),(3),(4)NA
23Meeting of Risk Management Committee21(3A)NA
24Vigil Mechanism22Yes
25Policy for related party Transaction23(1),(1A),(5),(6),(7) & (8)Yes
26Prior or Omnibus approval of Audit Committee for all related party transactions23(2), (3)Yes
27Approval for material related party transactions23(4)NA
28Disclosure of related party transactions on consolidated basis23(9)NA
29Composition of Board of Directors of unlisted material Subsidiary24(1)NA
30Other Corporate Governance requirements with respect to subsidiary of listed entity24(2),(3),(4),(5) & (6)NA

Annexure II

II. Annual Affirmations

SrParticularsRegulation NumberCompliance status (Yes/No/NA)If status is “No” details of non-compliance may be given here.
31Annual Secretarial Compliance Report24(A)Yes
32Alternate Director to Independent Director25(1)NA
33Maximum Tenure25(2)Yes
34Meeting of independent directors25(3) & (4)Yes
35Familiarization of independent directors25(7)NA
36Declaration from Independent Director25(8) & (9)Yes
37D & O Insurance for Independent Directors25(10)NA
38Memberships in Committees26(1)Yes
39Affirmation with compliance to code of conduct from members of Board of Directors and Senior management personnel26(3)Yes
40Disclosure of Shareholding by Non-Executive Directors26(4)Yes
41Policy with respect to Obligations of directors and senior management26(2) & 26(5)Yes
Any other information to be provided - Add Notes




Annexure II

1Name of signatorySWEETY MAMODIA
2DesignationCompany Secretary and Compliance Officer



Annexure II

III. Affirmations

SrParticularsCompliance status (Yes/No/NA)
1The Listed Entity has approved Material Subsidiary Policy and the Corporate Governance requirements with respect to subsidiary of Listed Entity have been compliedNA
Any other information to be provided




Annexure II

1Name of signatorySWEETY MAMODIA
2DesignationCompany Secretary and Compliance Officer



Signatory Details

Name of signatorySWEETY MAMODIA
Designation of personCompany Secretary and Compliance Officer
PlaceJAIPUR
Date14-05-2020